Health-related quality of life in cutaneous T-cell lymphoma: A cross-sectional survey study [0.03%]
皮肤T细胞淋巴瘤患者的生活质量研究：横断面调查研究
M M Shinohara,H M Mahurin,E Tarabadkar et al.
M M Shinohara et al.
Background: Patients with cutaneous T-cell lymphoma (CTCL) often have indolent but symptomatic disease. Objective: Assessment of the he...
A structured review of quality of life in advanced and high-risk cutaneous squamous cell carcinoma shows the need for more studies and better measures [0.03%]
系统评价显示：需加强对晚期和高危皮肤鳞状细胞癌的生活质量研究及更好衡量标准
R Starkings,V Shilling,V Jenkins et al.
R Starkings et al.
Background: Cutaneous squamous cell carcinoma (cSCC) accounts for nearly a quarter of non-melanoma skin cancers. Studies reporting Quality of Life (QoL) in this group focus on early stage disease. A small proportion of cS...
Inspired by vitamin A for anti-ageing: Searching for plant-derived functional retinoid analogues [0.03%]
受维生素A启发的抗衰老研究：寻找植物来源的功能性类视黄醇成分
N J Sadgrove,J E Oblong,M S J Simmonds
N J Sadgrove
Background: Cosmetic treatments that inspire one's appearance to resemble their younger portrait often utilize ingredients that confer acute effects, particularly hydration by creating hydrophobic barriers or transient el...
Prevalence, determinants and perception of use of skin lightening products among female medical undergraduates in Nigeria [0.03%]
尼日利亚女医学生使用皮肤美白产品的情况、决定因素及感知研究
O G Egbi,B Kasia
O G Egbi
Background: Skin Lightening Products (SLP) are common in Africa especially in Nigeria. Adverse effects from these products present a public health concern. Data on the use of these products among medical students is scant...
Laser therapy for genital lichen sclerosus: A systematic review of the current evidence base [0.03%]
激光治疗生殖器扁平苔藓的现有证据体系综述
F Tasker,L Kirby,D J C Grindlay et al.
F Tasker et al.
Background: Lichen sclerosus (LS) is a chronic, inflammatory dermatosis. Initial treatment with superpotent topical corticosteroids is the accepted and evidence-based first-line therapy. For those who do not respond after...
Skin cancer diagnosis in renal transplant recipients during the Covid-19 pandemic [0.03%]
新冠肺炎流行期间肾移植受者的皮肤癌诊断
E Keeling,J Hynes,E K Pender et al.
E Keeling et al.
Edgar Mandeng Ma Linwa,Odette Berline Sigha,Angelique Jacquie Djeumen Touka et al.
Edgar Mandeng Ma Linwa et al.
Introduction: With the advent of COVID-19, a highly infectious viral pandemic, first declared in Cameroon in March 2020, access to expert dermatology care was postulated to decrease. We carried out a descriptive study to ...
Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID-19 [0.03%]
雄激素性脱发与新冠肺炎流行病学和遗传关联的系统研究
S K Henne,L M Hochfeld,C Maj et al.
S K Henne et al.
Background: Male androgenetic alopecia (AGA) has been implicated as a putative risk factor in severe COVID-19 based on high incidences of advanced AGA in male hospitalized COVID-19 patients. Research further suggests that...
Assessing the effects of common topical exposures on skin bacteria associated with atopic dermatitis [0.03%]
评估常见的局部接触对特应性皮炎相关皮肤细菌的影响
C R Castillo,M E Alishahedani,P Gough et al.
C R Castillo et al.
Background: While patients and families struggling with atopic dermatitis (AD) have documented concerns for a contributory role of skin care products in AD pathology, nearly all the skin microbiome studies to date have as...
Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma [0.03%]
folate水解酶-1（FOLH1）是默克尔细胞癌抗体介导的近距离放射治疗的新靶点
M K Ramirez-Fort,B Meier-Schiesser,K Lachance et al.
M K Ramirez-Fort et al.
Backgrounds: Folate Hydrolase-1 (FOLH1; PSMA) is a type II transmembrane protein, luminally expressed by solid tumour neo-vasculature. Monoclonal antibody (mAb), J591, is a vehicle for mAb-based brachytherapy in FOLH1+ ca...